Salvatore Salamone, Jim Manzi | GenomeWeb

Salvatore Salamone, Jim Manzi

Premium
US Genomics has named Salvatore Salamone to its board of directors.
 
Salamone is chairman and CEO of Saladax Biomedical. He formerly was vice president of R&D at Roche Diagnostics and was senior vice president of R&D at Orasure Technologies.
 

 
Thermo Fisher Scientific has named director Jim Manzi as non-executive chairman of its board.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.